Abernethy’s Departure From US FDA Gives Next Commissioner Options For A New Number Two

 
• By Kate Rawson
THE QUESTION OF WHO WILL BE THE US FDA’S NUMBER TWO IS STARTING TO LOOM ALMOST AS LARGE AS WHO WILL BE THE COMMISSIONER.

More from US FDA

More from Agency Leadership